The Hollings Cancer Center has conducted extensive research on Ellagic acid and they have been very impressed with what they have discovered. In fact, they are now doing a double blind study on a large group of 500 cervical cancer patients. Their past nine years of study have shown that ellagic acid is causing G-arrest within 48 hours (inhibiting and stopping mitosis-cancer cell division), and apoptosis (normal cell death) within 72 hours, for breast, pancreas, esophageal, skin, colon and prostate cancer cells.